Centessa Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019
Period Ending	Oct '25 Oct 23, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019
Market Capitalization	2,434	1,764	610	243	748	-	Upgrade
Market Cap Growth	59.38%	189.13%	150.68%	-67.44%	-	-	Upgrade
Enterprise Value	2,334	1,418	455	-69	320	-	Upgrade
Last Close Price	18.24	12.71	-	-	-	-	Upgrade
PS Ratio	222.28	-	113.40	-	-	-	Upgrade
PB Ratio	9.67	5.50	3.29	0.87	2.06	-	Upgrade
P/TBV Ratio	9.67	5.50	3.29	0.87	2.06	-	Upgrade
EV/Sales Ratio	207.02	-	84.53	-	-	-	Upgrade
Debt / Equity Ratio	0.34	0.29	0.36	0.21	0.15	1.82	Upgrade
Asset Turnover	0.03	-	0.02	-	-	-	Upgrade
Quick Ratio	9.93	9.10	7.51	10.97	24.84	1.18	Upgrade
Current Ratio	10.12	9.25	8.00	11.42	25.52	1.30	Upgrade
Return on Equity (ROE)	-72.92%	-73.93%	-52.79%	-52.24%	-154.41%	-	Upgrade
Return on Assets (ROA)	-28.96%	-26.82%	-26.61%	-24.48%	-27.16%	-	Upgrade
Return on Capital (ROIC)	-30.88%	-29.91%	-29.46%	-27.01%	-30.24%	-	Upgrade
Earnings Yield	-6.91%	-10.67%	-19.44%	-73.73%	-37.73%	-	Upgrade
FCF Yield	-4.32%	-6.43%	-20.65%	-68.77%	-13.47%	-	Upgrade
Buyback Yield / Dilution	-27.54%	-19.02%	-2.97%	-24.26%	-401.11%	-	Upgrade

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.